Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients

Upsala Journal of Medical Sciences

Volumn 108, Issue 1, 2003, Pages 61-74

  Almroth, G ^a   Uhlin, F ^a   Ekermo, B ^a   Isaksson, B ^a   Kaijser, B ^b   Andersson, B ^b   Hahn Zoric, M ^b   Sallberg M ^c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN SUBCLASS; PNEUMOCOCCUS VACCINE; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; MALE; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; VACCINATION; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; RENAL REPLACEMENT THERAPY;

CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; MALE; PNEUMOCOCCAL VACCINES; RENAL DIALYSIS;

EID: 2142738803     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-123     Document Type: Review

References (43)

1. Buti, M., Viladomiu, L., Jardi R. et al. 1992. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12: 144-7.
2. Beaman, M., Michael, J., Mac Lennan, I.C.M., Adu, D. 1989. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant 4: 216-21.
3. Mettang, T., Schenk, U., Thomas, S. et al. 1996. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. Nephron 72: 192-6.
4. Versluis, D.,J., Beyer, W.E.P., Masurel, N., Diderich, P,P,, Kramer, P., Weimar, W. 1988. Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis. Nephron 49: 16-9.
5. Bhandari, S., Farr, M.J., Sellars, L. 1995. Influenza vaccination in renal patients (letter). Nephrol Dial Transplant; 10: 912-3.
6. Borradori, L., Born, B., Descoeudres, C., Skvaril, F., Morell, A. 1990. Serum immunoglobulin levels and natural antibodies to Haemophilus Influenzae in hemodialysis patients: Evidence for IgG subclass imbalances Nephron 56: 35-9.
7. Borzi, R.M., Dal Monte, P., Honorati, M.C., Facchini, A. 1992. IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HbsAg. J Immunol Meth 146: 17-23.
8. Skvaril, F., Joller-Jemelka, H. 1984. IgG subclasses of anti-HBs antibodies in vaccinated and non-vaccinated individuals and in anti-HBs immunoglobulin preparations. Int Archs Allergy Appl Immun; 73: 330-7.
9. Kaijser B. 1979. Pneumococcal infections and the possible need for a vaccine. Scand J Infect Dis 11: 179-84.
10. Örtqvist, Å., Hedlund, J., Kalin, M. 1999. The elderly should be vaccinated against pneumococci. Läkartidningen (Swedish, Eng. abstr.) 96: 1305-8.
11. Simberkoff, M.S., Schiffner, G., Katz, L.A., Spicehandler, J.R., Moldover, N.H., Rahal, J.J. Jr. 1980. Pneumococcal capsular polysaccharide vaccination in adult hemodialysis patients. J Lab Clin Med 96: 363-70.
12. Jefferis, R., Reimer, C.B., Skvaril, F. et al. 1985. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: Results of an IUS/ WHO collaborative study Immunol. letters 10: 223-52.
13. Sällberg, M., Magnius, L.O. 1989. An enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc J Clin Microbiol 27: 849-53.
14. Sällberg, M., Ruden, U., Wahren, B., Noah, M., Magnius, L.O. 1991. Human and murine B-cells recognize the HBeAg/ Beta (or HBe2) epitope as a linear determinant. Mol Immunol 28: 719-26.
15. Almroth, G., Ekermo, B., Månsson, A.-S., Svensson, G., Widell, A. 2002. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long term follow up (1989-January 1997). J Int Med 251: 119-28.
16. Van Biesen, N., Wiedemann, M., Lameire, N. 1998. End-stage renal disease treatment: a european perspective. J Am Soc Nephrol; 9: 55-62.
17. Struve, J., Aronsson, B., Forsgren, M., Frenning, B., von Sydow, M., Weiland, O. 1996. Hepatit B yrkesrisk för vårdpersonal (Swedish). Läkartidningen 93: 884-8.
18. Walz, G., Kunzendorf, U., Haller, H. et al. 1989. Factors influencing the response to hepatitis B vaccination of hemodialysis patients. Nephron 51: 474-7.
19. Honorati, M.C., Borzi, R.M., Dolzani, P., Toneguzzi, S., Facchini, A. 1997. Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine. Int J Clin Lab Res; 27: 202-6.
20. Nielsen, H., Kvinesdal, B., Benfield, T.L., Lundgren, J.D., Konradsen, H.B. 1998. Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection. Scand J Infect Dis 30: 597-601.
21. Vidarsson, G., Sigudardottir, S.T., Gudnason, T. et al. 1998. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun 66: 2866-70.
22. Soininen, A., Seppälä, I., Nieminen, T., Eskola, J., Käyhty, H. 1999. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine 17: 1889-97.
23. Bossen Konradsen H. 1996. Humoral immune response to pneumococcal vaccination, prevention of infections with streptococcus pneumoniae by immunization. APMIS 104 (suppl 60): 5-28.
24. Eskola, J., Kilpi, T., Palmu, A. et al. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403-09.
25. Burman, L.G., Fryklund, B., Linglöf, T. 1996. Sjukvå rdspersonal vaccineras mot hepatit B. Lokal anpassning till socialstyrelsens rekommendation. Läkartidningen (Swedish); 93: 566-8.
26. Crosnier, J., Degos, F., Jungers, P. 1989. Dialysis-associated hepatitis. In Maher JF, ed, Replacement of Renal Function by Dialysis. Dordrecht: Kluwer Academic Publishers: 881-903.
27. Roll, M., Norder, H., Magnius, L.O., Grillner, L., Lindgren, V. 1995. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV-DNA sequencing. J Hosp Infect 30: 57-63.
28. Arvilommi, H. 1996. Elispot for detecting antibody-secreting cells in response to infections and vaccination. APMIS 104: 401-10.
29. Dumann, H., Meuer, S., Meyer zum Büschenfelde, K.-H., Köhler H. 1990. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. Kidney Int 38: 1164-8.
30. Struve, J., Aronsson, B., Frenning, B., Forsgren, M., Weiland, O. 1995. Response to a booster dose after a low anti-HBs response (10-99 IU/l) to three doses of intra-dermally or intramuscularly administred recombinant hepatitis B vaccine. Infection; 23: 42-5.
31. Fuchshuber, A., Kühnemund, O., Kenth. 1996. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 11: 468-73.
32. Docci, D., Cipolloni, P.A., Mengozzi, S., Bazdratil, L., Capponcini, C., Feletti, C. 1992. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: A two-year follow-up. Nephron 61: 352-3.
33. Grekas, D., Dioudis, C., Mandravelli, K. 1995. Renal transplantation in asymptomatic carriers of hepatitis B surface antigen. Nephron 69: 267-72.
34. Combined report on regular dialysis and transplantation in Europe 1990, 21st conference of the European Dialysis and Transplant Association-European Renal Association. 1991. Nephrol. Dial. Transplant. 6: 28.
35. Haubitz, M., Ehlerding, G., Beigel, A. 1996. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency. Clin. Nephrol. 45: 180-2.
36. Peces, R., Laures, A.S. 2001. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response. Nephron 89: 172-6.
37. Fabrizi, F., Martin, P., Ponticelli, C. 2002. Hepatitis B virus and renal transplantation. Nephron 90: 241-51.
38. Sennesael, J., van der Niepen, P., Verbeelen, D.L. 1991. Treatment with erythropoeitin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int. 40: 121-8.
39. Caillat-Zucman, S., Gimenez, J.J., Albouze, G. et al. 1993. HLA genetic heterogenity of hepatitis B vaccine response in hemodialyzed patients. Kidney Int-Suppl. June; 41: S 157-60.
40. Tokars, J.I., Arduino, M.J., Alter M.J. 2001. Infection control in hemodialysis units. Infect Dis Clin North Am 15: 797-812.
41. Fernandez, E., Betriu, M.A., Gomez, R. et al. 1996. Response to hepatitis B virus vaccine in hemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 11: 1559-63.
42. Chang, M.H., Chen, C.J., Lai, M.S., et al. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N Engl J Med 336: 1906-7.
43. Ni, Y.H., Chang, M.H., Huang, L.M. et al. 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135: 796-800.